Bioprocessors have had a good handle on viral safety, but they need to keep their grip as they shift toward continuous processing and boost production of...
Eli Lilly has struck an $812.5 million agreement with the US government to supply an additional 650,000 vials of its bamlanivimab (LY-CoV555), an investigational neutralizing antibody, for the...
A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a The post iRhythm digital heart monitoring service backed...
As the pandemic wears on, some people struggle to keep adhering to restrictions and social distancing guidelines. There are psychological reasons for caution fatigue, and ways...
Switzerland’s Roche Holding AG announced on Wednesday that its Elecsys test, which seeks to detect antibodies against the SARS-CoV-2 spike protein, has been granted emergency use...
Health inequalities are a long-term condition and inclusive research is the only disease modifying therapy in the pipeline The post Inclusive research and tackling health inequalities...
During the first wave of the coronavirus pandemic, from late March to early August, Myanmar recorded just 360 cases and 6 deaths. Early in the crisis,...
A machine learning model developed in Finland can help us treat cancer more effectively Credit: Matti Ahlgren, Aalto University When healthcare professionals treat patients suffering from...
Intellect, a Singapore-based startup that wants to lower barriers to mental health care in Asia, says it has reached more than one million users just six...
The article by Dr. Alberto Boretti and colleagues is published in Coronaviruses, 2020 Credit: Dr. Alberto Boretti, Dr. Bimal Banik, Dr. Stefania Castelletto, Bentham Science Publishers...
Genmab has axed development of its pipeline cancer drug enapotamab vedotin after it failed to show enough activity The post Genmab axes development of AXL-targeting cancer...
The coronavirus pandemic has been a stressful and challenging time. But staying busy can help by creating a diversion, helping us to build community and strengthening...
FibroGen and its partner, Astellas Pharma, announced on November 27 that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved EVRENZO (roxadustat) for the treatment of...
Rhythm Pharmaceuticals (RYTM) announced on November 27 that the FDA has approved IMCIVREE (setmelanotide) for chronic weight management in adult and pediatric patients age 6 years...
COVID Antibody Drugs From Regeneron, Eli Lilly Raise Concerns About Supply Shortages Tyler Durden Sat, 11/28/2020 - 17:30 Powerful drugs recently authorized by the FDA are...
Biogen will take a $650 million stake in Sage Therapeutics and make an upfront payment of $875 million to jointly develop and sell treatments for depression...
Expectations of good news on the near horizon are buoying markets right now. Over the past month, both the S&P 500 and the NASDAQ are up...
But the research to support advances in clinical practice is still catching up.
Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be The post Cheap gout drug colchicine added to...
Y-mAbs Therapeutics announced that the US Food and Drug Administration (FDA) has approved its Danyelza (naxitamab) antibody therapy for the treatment of cancer patients with neuroblastoma....
Germany’s healthcare and chemicals group Merck KGaA announced a €10 million ($11.9 million) partnership with Siemens to digitalize and automate modular production. As part of the...
AstraZeneca Plc is likely to do another global trial to assess the efficiency of its COVID-19 vaccine as the drugmaker tries to clear up uncertainty and...
The US government has introduced a scheme to allow hospitals to reduce the number of inpatients they see The post As COVID-19 cases swell, US extends...
We shouldn't paint all those hesitant or unsure about new medical treatments with the same broad brush. We need a more productive and thoughtful conversation.
Plasma from recovered patients shows little benefit in those hospitalized with COVID-19: study (Reuters) – Using blood plasma from COVID-19 survivors to treat patients with severe...
Vaccines are being touted as taking seven to ten years to develop. But you shouldn't be worried that COVID vaccines only took less than a year.
U.S. Surgeon General Jerome Adams pleaded with Americans to grasp “the severity of the moment” and remain vigilant against the coronavirus pandemic, as record hospitalizations pushed...
Credit: John Underwood/Purdue University WEST LAFAYETTE, Ind. – A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections,...
The Ottawa Hospital, Algonquin College, University of Ottawa and Mitacs partner on five-year training program Credit: The Ottawa Hospital As COVID-19 highlights the urgent need to...
The U.S. government will start distributing Regeneron Pharmaceuticals Inc.’s newly authorized Covid-19 antibody combination on Nov. 24, beginning with more than 30,000 treatment courses, a health...